Acute Hepatic Porphyria (AHP)

DBCOND0109617Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesMental Disorders

Acute Hepatic Porphyria (AHP) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Acute Hepatic Porphyria
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT124624007MedDRA10000818UMLSC0162565

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Acute Hepatic Porphyria (AHP) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In